Flash e-reader

 Go to e-reader chapter








PDF FormatRequires Adobe Acrobat Reader

Table 5.6g

Immunosuppression Use for Maintenance Between Discharge

and One Year Following Transplantation, 1999 to 2008

Recipients with Kidney Transplants

  Year of Transplant
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
Transplants 12,765 13,620 14,276 14,779 15,137 16,006 16,483 17,095 16,634 16,521
Tx with Follow-up Immunosuppression Info 11,023 11,812 12,724 13,234 13,555 14,252 14,692 15,248 14,771 14,766
Corticosteroids Any in Category 98.5% 96.7% 95.6% 91.7% 86.0% 80.5% 75.9% 71.0% 69.2% 70.4%
Steroids 98.5% 96.7% 95.6% 91.7% 86.0% 80.5% 75.9% 71.0% 69.2% 70.4%
Cyclosporine Any in Category 63.7% 53.2% 39.5% 32.4% 26.9% 22.5% 16.0% 13.0% 11.3% 8.6%
Cyclosporin 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.0% 0.1% 0.1% 0.2%
Sandimmmune 8.5% 5.1% 3.3% 1.6% 1.2% 1.0% 0.7% 0.6% 0.5% 0.5%
Neoral 55.1% 45.9% 30.0% 23.4% 18.6% 15.1% 10.3% 8.3% 7.8% 5.7%
Gengraf 0.1% 2.2% 6.1% 7.3% 6.9% 6.2% 4.9% 4.0% 2.8% 2.0%
Eon 0.0% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1%
Tacrolimus Any in Category 42.8% 52.7% 63.8% 69.2% 72.5% 76.4% 82.7% 85.1% 87.8% 90.0%
Tacrolimus 42.8% 52.7% 63.8% 69.2% 72.5% 76.4% 82.7% 84.9% 87.4% 89.5%
Everolimus 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.2% 0.4% 0.5%
Antimetabolites Any in Category 89.4% 84.3% 83.6% 85.3% 85.3% 86.8% 90.7% 91.1% 92.9% 93.4%
Mycophenolate Mofetil 78.1% 76.5% 77.6% 80.5% 81.8% 82.3% 81.8% 74.9% 72.2% 70.1%
Mycophenolate Sodium 0.2% 0.0% 0.0% 0.3% 0.5% 2.4% 6.7% 13.7% 18.1% 20.0%
Azathioprine 11.0% 7.6% 6.0% 4.4% 2.8% 1.9% 1.6% 1.7% 1.7% 2.0%
Leflunomide 0.0% 0.2% 0.0% 0.1% 0.2% 0.3% 0.6% 0.9% 0.9% 1.3%
Cytoxan 0.1% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
mTOR Inhibitors Any in Category 5.9% 16.6% 21.6% 21.7% 21.0% 18.5% 16.6% 14.1% 9.4% 7.9%
Sirolimus 5.2% 16.5% 21.5% 21.1% 21.0% 18.3% 16.4% 13.5% 9.0% 7.9%
Everolimus 0.7% 0.1% 0.1% 0.6% 0.0% 0.2% 0.3% 0.6% 0.4% 0.0%


Source: OPTN/SRTR Data as of October 1, 2010.

Percentages are calculated based on the total number of patients with any immunosuppression use between discharge and one year following transplantation.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may be prescribed more than one drug within

the same category.